Our team has decades of experience in managing brands, portfolios, and departments. We provide strategic analyses and recommendations that are both meaningful and actionable. We have been involved in due diligence all around the world assessing both drug and diagnostic assets.
We are driven by data. We analyze and interpret data to make strategic recommendations. We use recommendations to identify the best options that drive value.

Competitive benchmarking

New product planning

Situation analysis

Opportunity assessment

Promotional effectiveness and ROI

Secondary data analysis

Pipeline and portfolio gap analysis

Asset prioritization
